CHE — Chemed Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Chemed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,080	2,139	2,135	2,264	2,431
Cost of Revenue
Gross Profit	701	770	765	799	854
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,690	1,796	1,791	1,924	2,065
Operating Profit	390	343	343	341	366
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	396	350	330	350	399
Provision for Income Taxes
Net Income After Taxes	319	269	250	273	302
Net Income Before Extraordinary Items
Net Income	319	269	250	273	302
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	319	269	250	273	302
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	18.2	18.3	17.2	18.6	21.2
Dividends per Share